GRANITE: Airsupra Effectiveness in the Real World

计划入组 4,060 人 · 首次发布于 2025 年 8 月 26 日

Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

计划入组 1,390 人 · 首次发布于 2007 年 6 月 11 日

A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial

计划入组 52 人 · 首次发布于 2013 年 1 月 14 日

Aranoza

Monoclonal antibody therapeutic (Granite Bio AG)

Adanate, Inc.

United States

Granite Bio AG

Switzerland

ARANO, LLC

United States

NUBEQA® (darolutamide) Plus ADT Significantly Improves Outcomes in Metastatic Hormone-Sensitive Prostate Cancer

NUBEQA® (darolutamide) Plus ADT Significantly Improves Outcomes in Metastatic Hormone-Sensitive Prostate Cancer

ARANOTE Trial: Nubeqa Plus ADT Significantly Improves Outcomes in mHSPC